SC-101

DRUG2 trials

Sponsors

Tianjin ConjuStar Biologics Co., Ltd.

Conditions

Advanced Solid TumorHR+ Breast CancerTNBC - Triple-Negative Breast Cancer

Phase 1

Study SC-101 in Subjects With Advanced Malignancies

RecruitingNCT06220838

Tianjin ConjuStar Biologics Co., Ltd.Advanced Solid Tumor

Start: 2024-02-02End: 2026-09-30Target: 100Updated: 2025-07-29

Phase 2

SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers

Not yet recruitingNCT07080619

Tianjin ConjuStar Biologics Co., Ltd.HR+ Breast Cancer, TNBC - Triple-Negative Breast Cancer

Start: 2025-09-20End: 2027-12-30Target: 120Updated: 2025-09-11